How to Buy Genedx Holdings Stock
Genedx Holdings Corp
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
Genedx Holdings stock last closed at $160.38, down 0.14% from the previous day, and has increased 113.69% in one year. It has overperformed other stocks in the Health Information Services industry by 1.67 percentage points. Genedx Holdings stock is currently +190.69% from its 52-week low of $55.17, and -6.14% from its 52-week high of $170.87.
There are currently 28.9M shares of WGS outstanding. The market cap of WGS is $4.64B. In the last 24 hours, 466,000 WGS shares were traded.
How to Buy Genedx Holdings Stock
Not sure how to invest in Genedx Holdings stock? Here's how.
- Figure out where to buy Genedx Holdings stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Genedx Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your payment method and add your information.
- Analyze Genedx Holdings stock: The Genedx Holdings ticker symbol is WGS. Is Genedx Holdings stock a good investment? Should you buy shares of WGS? How do WGS's underlying business fundamentals look? Do top analysts think Genedx Holdings is a good buy? Why has WGS's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if WGS is a good stock to buy).
- Place your WGS buy order: Decide if you will purchase WGS shares at the current market price or use a limit order to buy WGS shares at a given price.
- Keep an eye on your WGS investment: Create a watchlist to keep tabs on your position in Genedx Holdings stock.
Step 1: Figure out where to buy Genedx Holdings stock
You need a brokerage account in order to access the NASDAQ market and buy WGS shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you can buy WGS today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on the greatest app to buy stocks, you can securely and quickly fund your account:
Check out this video walkthrough if you need help depositing money into your new investment account.
Step 4: Analyze Genedx Holdings stock
After you have figured out the best place to buy Genedx Holdings stock, it's important to evaluate their stock before you buy, so you can understand the risk as well as the opportunity.
Genedx Holdings stock quick numbers
Genedx Holdings Due Diligence Checks
WallStreetZen was created to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on WGS's stock page.
Is WGS stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge WGS's intrinsic value.
Using relative valuations measures:
- WGS may be overvalued based on its P/E ratio of 1,457.95x, relative to Health Information Services industry P/E ratio of 48.93x
- WGS could be overvalued based on its P/B ratio of 15.86x, relative to Health Information Services industry P/B ratio of 4.13x
- WGS may be overvalued based on its PEG ratio of 11.31x
You can access more valuation research on WGS's stock here.
WGS Financial Overview
Pros:
- There are more short-term assets than long-term liabilities on the WGS balance sheet.
- There are more short-term assets than short-term liabilities on the WGS balance sheet.
- Total WGS debt is lower than 5 years ago, relative to shareholder equity.
- WGS profit margin has gone up from -31.2% to 0.5% in the past year.
- WGS's operating cash flow of $33.19M allows it to safely service it's debt of $113.16M.
Cons:
- WGS has a relatively high debt to equity ratio of 0.69.
- WGS earnings of $5.22M is not enough to cover its interest payments.
Is WGS stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 5 sell side analysts who monitor WGS, the consensus analyst rating on WGS is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Genedx Holdings stock forecast page.
Metrics for Advanced WGS Traders
How is WGS performing as a company?
Last year, WGS earnings were $2.08M. During the last four year, WGS's earnings have grown by -99.22% per year. This was slower than the Health Information Services industry average of 23.05%.
Last year, WGS revenue was $402.19M. In the past 4 year, WGS's revenue has gone up by 16.5% per year. This was slower than the Health Information Services industry average of 26.94%.
You can analyze WGS's earnings and revenue performance here.
Latest Insiders Trades at WGS
In the past 12 months, executives and large shareholders at WGS have sold more shares than they have bought.
Kevin Feeley, CHIEF FINANCIAL OFFICER of WGS, was the latest WGS insider to sell. They sold $61,276.07 worth of WGS shares on Dec 1, 2025.
Get more info about who owns WGS shares here.
Can I rely on WGS as an income stream?
No, Genedx Holdings doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your WGS buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and eToro will execute your order.
If you need more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your WGS investment
Now that you own some WGS shares, you'll want to stay up-to-date on your company.
Put WGS on a watchlist to get alerted to the latest events about your WGS stock.
WGS Feed
How to Buy Stock in Genedx Holdings
To summarize, here are the 6 steps you need to take to buy Genedx Holdings stock right now:
- Figure out where to buy Genedx Holdings stock
- Open a brokerage account
- Put funds into your brokerage account
- Analyze Genedx Holdings stock
- Place your WGS buy order
- Keep an eye on your WGS investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your investment in Genedx Holdings, create your watchlist below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.